184 related articles for article (PubMed ID: 18778304)
1. Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol.
Placzek EA; Okamoto Y; Ueda N; Barker EL
J Neurochem; 2008 Nov; 107(4):987-1000. PubMed ID: 18778304
[TBL] [Abstract][Full Text] [Related]
2. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide.
McFarland MJ; Porter AC; Rakhshan FR; Rawat DS; Gibbs RA; Barker EL
J Biol Chem; 2004 Oct; 279(40):41991-7. PubMed ID: 15292270
[TBL] [Abstract][Full Text] [Related]
3. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells.
McFarland MJ; Bardell TK; Yates ML; Placzek EA; Barker EL
Mol Pharmacol; 2008 Jul; 74(1):101-8. PubMed ID: 18436710
[TBL] [Abstract][Full Text] [Related]
4. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
Day TA; Rakhshan F; Deutsch DG; Barker EL
Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795
[TBL] [Abstract][Full Text] [Related]
5. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
[TBL] [Abstract][Full Text] [Related]
6. Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.
Bardell TK; Barker EL
Neurochem Int; 2010 Aug; 57(1):76-83. PubMed ID: 20466028
[TBL] [Abstract][Full Text] [Related]
7. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.
Rakhshan F; Day TA; Blakely RD; Barker EL
J Pharmacol Exp Ther; 2000 Mar; 292(3):960-7. PubMed ID: 10688610
[TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells.
Someya A; Horie S; Murayama T
Eur J Pharmacol; 2002 Aug; 450(2):131-9. PubMed ID: 12206851
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.
Bisogno T; Sepe N; Melck D; Maurelli S; De Petrocellis L; Di Marzo V
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):671-7. PubMed ID: 9065792
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.
Cadas H; Gaillet S; Beltramo M; Venance L; Piomelli D
J Neurosci; 1996 Jun; 16(12):3934-42. PubMed ID: 8656287
[TBL] [Abstract][Full Text] [Related]
11. Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide).
Placzek EA; Cooper BR; Placzek AT; Chester JA; Davisson VJ; Barker EL
J Pharm Biomed Anal; 2010 Nov; 53(3):567-75. PubMed ID: 20417049
[TBL] [Abstract][Full Text] [Related]
12. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol.
Beltramo M; Piomelli D
Neuroreport; 2000 Apr; 11(6):1231-5. PubMed ID: 10817598
[TBL] [Abstract][Full Text] [Related]
13. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
14. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.
Placzek EA; Okamoto Y; Ueda N; Barker EL
Neuropharmacology; 2008 Dec; 55(7):1095-104. PubMed ID: 18760289
[TBL] [Abstract][Full Text] [Related]
15. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
17. Receptor-dependent formation of endogenous cannabinoids in cortical neurons.
Stella N; Piomelli D
Eur J Pharmacol; 2001 Aug; 425(3):189-96. PubMed ID: 11513837
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin.
Bisogno T; Melck D; De Petrocellis L; Di Marzo V
J Neurochem; 1999 May; 72(5):2113-9. PubMed ID: 10217292
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
Porter AC; Sauer JM; Knierman MD; Becker GW; Berna MJ; Bao J; Nomikos GG; Carter P; Bymaster FP; Leese AB; Felder CC
J Pharmacol Exp Ther; 2002 Jun; 301(3):1020-4. PubMed ID: 12023533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
